Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

9.220 -0.380 (-3.96%)

Delayed Quote Updated: 10:46 AM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gossamer Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

What 4 Analyst Ratings Have To Say About Gossamer Bio ↗

September 19, 2022

Within the last quarter, Gossamer Bio (NASDAQ:GOSS) has observed the following analyst ratings:

Via Benzinga

Where Gossamer Bio Stands With Analysts ↗

September 19, 2022

Within the last quarter, Gossamer Bio (NASDAQ:GOSS) has observed the following analyst ratings:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2022 ↗

September 19, 2022

Upgrades

Via Benzinga

Analyst Ratings for Gossamer Bio ↗

September 19, 2022

Gossamer Bio (NASDAQ:GOSS) has observed the following analyst ratings within the last quarter:

Via Benzinga

Gossamer Bio: Q2 Earnings Insights ↗

August 09, 2022

Gossamer Bio (NASDAQ:GOSS) reported its Q2 earnings results on Tuesday, August 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Where Gossamer Bio Stands With Analysts ↗

April 26, 2022

Analysts have provided the following ratings for Gossamer Bio (NASDAQ:GOSS) within the last quarter:

Via Benzinga

Gossamer Bio Pulls Plug On Mid-Stage Ulcerative Colitis Program ↗

April 25, 2022

Via Benzinga

Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update

August 09, 2022

From Gossamer Bio, Inc.

Via Business Wire

Beyond Meat, Canoo, Veru And More: 12 Short Squeeze Candidates To Watch ↗

July 20, 2022

One of the most powerful tradable market events is a short squeeze, so traders are always on the lookout for the next short squeeze candidate. S3 Partners analyst Ihor Dusaniwsky has just released a...

Via Benzinga

Insider Buying This Major Airline Stock, Here's 3 Stocks Insiders Are Buying ↗

July 18, 2022

Although US stocks closed higher on Friday, there were a few notable insider trades.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 14, 2022

Via Benzinga

Recap: Gossamer Bio Q4 Earnings ↗

March 03, 2022

Gossamer Bio (NASDAQ:GOSS) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday ↗

July 15, 2022

Gainers

Via Benzinga

Dow Sinks Amid Disappointing Data, Bank Earnings ↗

July 14, 2022

Wall Street worries over potential rate hikes from the Fed following yesterday's inflation reading.

Via Talk Markets

Analyst Ratings for Gossamer Bio ↗

July 14, 2022

Over the past 3 months, 5 analysts have published their opinion on Gossamer Bio (NASDAQ:GOSS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday ↗

July 14, 2022

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 13, 2022

Via Benzinga

Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session ↗

July 13, 2022

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program ↗

July 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 13, 2022

Via Benzinga

Gossamer Bio Announces $120 Million Private Placement Financing

July 13, 2022

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio Announces Publication of Key Preclinical Data in the European Respiratory Journal Highlighting Seralutinib’s Potential for the Treatment of PAH

June 09, 2022

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio Announces First Quarter 2022 Financial Results and Provides Business Update

May 10, 2022

From Gossamer Bio, Inc.

Via Business Wire

71 Biggest Movers From Yesterday ↗

April 27, 2022

Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 25, 2022

Via Benzinga

Gossamer Bio Announces GB004 Topline Results from Phase 2 SHIFT-UC Study in Ulcerative Colitis and Provides Corporate Update

April 25, 2022

From Gossamer Bio, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022 ↗

April 18, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 06, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 32.4% to $7.43 during Wednesday's regular session. Sunshine Biopharma's stock is trading at a volume of 46.8...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 ↗

April 06, 2022

Upgrades

Via Benzinga

Earnings Scheduled For March 3, 2022 ↗

March 03, 2022

Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.